news in brief Buckinghamshire health authority

Buckinghamshire health authority has announced that it is spending a further £130,000 on beta interferon treatment this year, allowing another eight multiple sclerosis patients to be treated, doubling the number treated. Patients had protested about the limited availability of the drug in Buckinghamshire.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here